About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
HYDROFLUMETHIAZIDE (ID 26372) exhibits a complex biochemical signature characterized by multi‑pathway modulation involving receptor interaction, enzymatic pathway alteration, mitochondrial signalling influence and transcription‑level regulation. Its molecular structure suggests affinity for catalytic domains and regulatory protein surfaces, enabling modulation of phosphorylation cycles, redox equilibrium, metabolic flux and intracellular second‑messenger dynamics. Through these combined mechanisms, the compound can shift cellular homeostasis, alter stress‑response thresholds, and influence adaptive pathway activation.
Benefits and Advantages
This compound is used extensively in advanced biochemical modelling, mechanistic pathway validation, receptor‑ligand binding experiments, ROS‑modulation studies, mitochondrial‑function assays, kinase/phosphatase cascade mapping and early‑stage pharmacodynamic screening. Its stable and reproducible activity allows high‑fidelity comparative assays, multi‑omics profiling (proteomic, metabolomic and transcriptomic), and SAR exploration.
- Supports high‑resolution mechanistic research
- Useful for controlled pathway perturbation models
- Applicable in metabolic and endocrine modelling
- Valuable for cytotoxicity, redox and stress‑response assays
Side Effects and Risks
Potential risks include mitochondrial overload, ROS imbalance, off‑target receptor or enzyme interactions, modulation of cytoskeletal integrity, calcium‑flux disruption and dose‑dependent apoptotic or autophagic signalling. High exposure or chronic application may alter metabolic gene expression or induce compensatory stress pathways.
Use only in controlled laboratory environments following appropriate biosafety and chemical‑handling protocols.
Datasheet
| Molecular Formula | C9H10ClFN3O4S2 |
|---|---|
| Molecular Weight | 331.3 g/mol |
| CAS Number | 135-09-1 |
| Storage Condition | Commercially available hydroflumethiazide tablets should be stored at room temperature (approximately 25 °C) … . |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | hydroflumethiazide; 135-09-1; Diuredemina; Diucardin; Glomerulin |
| IUPAC/Chemical Name | 1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide |
| InChl Key | DMDGGSIALPNSEE-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
